Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 27:jnis-2024-022315.
doi: 10.1136/jnis-2024-022315. Online ahead of print.

Flow-diverting stents for the treatment of unruptured distal anterior cerebral artery aneurysms: analysis of the CRETA Registry

Luca Scarcia  1 Frédéric Clarençon  2   3 Adam A Dmytriw  4   5 Eimad Shotar  2 Kevin Premat  2 Pascal Jabbour  6 Stavropoula I Tjoumakaris  6 Reid Gooch  6 Marios-Nikos Psychogios  7 Nikolaos Ntoulias  7 Peter B Sporns  8 Ajit S Puri  9 Jasmeet Singh  9 Anna Luisa Kuhn  9 Ameer E Hassan  10 Oktay Algin  11 Markus A Möhlenbruch  12 Sophia Hohenstatt  12 Riccardo Russo  13 Mauro Bergui  13 Oded Goren  14 Matthew J Kole  14 Nourou Dine Adeniran Bankole  15 Richard Bibi  15 Gregoire Boulouis  15 Takeshi Morimoto  16 Fumihiro Sakakibara  16 Raoul Pop  17 Ciprian Juravle  17 Joanna Wk Ho  18 Angel Ferrario  19 Virginia Pujol Lereis  20 Jared Cooper  21 Chirag D Gandhi  21 Giancarlo Salsano  22 Lucio Castellan  22 Arianna Camilli  23 Arturo Consoli  24   25 Alessandro Sgreccia  24 Eytan Raz  26 Charlotte Chung  26 Julien Burel  27 Chrysanthi Papagiannaki  27 Umair Rasheed  28 Khawaja Muhammad Baqir Hassan  28 Tao Hong  29 Zhe Ji  29 Riitta Rautio  30 Matias Sinislao  30 Maria Ruggiero  31 Elvis Lafe  31 Valerio Da Ros  32 Luigi Bellini  32 Joseph D Gabrieli  33 Giacomo Cester  33 Michael R Levitt  34 Kate T Carroll  34 Zack A Abecassis  34 Antonio Armando Caragliano  35 Sergio L Vinci  35 Guillaume Bellanger  36 Christophe Cognard  36 Gaultier Marnat  37 Lisa Saleille  37 Nicola Limbucci  38 Francesco Capasso  38 Mariangela Piano  39 Claudia Rollo  39 Alexis Guedon  40 Francesco Arpaia  40 Andrea Romi  41 Fortunato Di Caterino  42 Alessandra Biondi  42 Erwah Kalsoum  1 Vyval Mykola  43 Adrien Guenego  44 Aman B Patel  4 Vitor M Pereira  5 Alessandro Pedicelli  23   45 Andrea Maria Alexandre  46 CRETA investigators
Affiliations

Flow-diverting stents for the treatment of unruptured distal anterior cerebral artery aneurysms: analysis of the CRETA Registry

Luca Scarcia et al. J Neurointerv Surg. .

Abstract

Background: Data about the safety and the efficacy of flow diversion for distal anterior cerebral artery (DACA) aneurysms are limited. We present the largest multicenter analysis evaluating the outcomes of flow diversion in unruptured DACA aneurysm treatment.

Methods: Databases from 39 centers were retrospectively reviewed for unruptured DACA aneurysms treated with flow-diverting stents. Demographics, clinical presentation, radiographic characteristics, procedural complications, and outcomes were assessed.

Results: A total of 168 patients with 168 unruptured DACA aneurysms were treated between January 2018 and December 2022. One hundred and twenty-five were women (74.4%) and the median age was 61 (IQR 52-67) years. The most common morphology was saccular (91.7%), with branch involvement in 61.9% of cases. Median parent vessel diameter was 1.9 mm (IQR 1.7-2.2) and stents were successfully deployed in 99.4% of cases. In 96.4% a single stent was implanted, while 3.6% of cases required two stents. Median imaging follow-up was 16.5 (IQR 7-24) months. At last follow-up the rate of occlusion (O'Kelly-Marotta scale C or D) was 82.1%. Symptomatic thromboembolic or hemorrhagic complications occurred in 5.3% of patients and the mortality rate was 0.6%. The rate of retreatment was 1.2%.

Conclusions: Flow-diverting stents are a reasonably safe and effective treatment option for unruptured DACA aneurysms.

Keywords: Aneurysm; Angiography; Flow Diverter.

PubMed Disclaimer

Conflict of interest statement

Competing interests: TM: Outside the submitted work, received lecturer’s fees from Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Japan Lifeline, Pfizer, Tsumura and UCB; manuscript fee from Pfizer; advisory board for GlaxoSmithKline, Novartis and Teijin. FS: Outside the submitted work received lecturer’s fee from Idorsia Pharmaceuticals for the past 36 months. OG: Outside the submitted work, MicroVention proctor for the WEB device, Stryker consultant, Route 92 consultant.ML: Unrestricted educational grants from Medtronic and Stryker; consulting agreement with Aeaean Advisers, Metis Innovative, Genomadix, AIDoc and Arsenal Medical; equity interest in Proprio, Stroke Diagnostics, Apertur, Stereotaxis, Fluid Biomed, Synchron and Hyperion Surgical; editorial board of Journal of NeuroInterventional Surgery; Data safety monitoring board of Arsenal Medical. AMA: educational grants from Medtronic, Stryker, Balt and Microvention/Terumo unrelated to the current study. AP: educational grants from Medtronic, Stryker, Balt and Microvention/Terumo unrelated to the current study. AEH: Consultant/Speaker: Medtronic, Microvention, Stryker, Penumbra, Cerenovus, Genentech, GE Healthcare, Scientia, Balt, Viz.ai, Insera therapeutics, Proximie, NeuroVasc, NovaSignal, Vesalio, Rapid Medical, Imperative Care, Galaxy Therapeutics, Route 92, Perfuze, CorTech, Shockwave, Toro and Xcath. Principal Investigator: COMPLETE study – Penumbra, LVO SYNCHRONISE – Viz.ai, MARRS - Perfuze, RESCUE - ICAD - Medtronic. Steering Committee/Publication committee member: SELECT, DAWN, SELECT 2, EXPEDITE II, EMBOLISE, CLEAR, ENVI, DELPHI, DISTALS. DSMB - COMAND trial. ML Unrestricted educational grants from Medtronic and Stryker; consulting agreement with Aeaean Advisers, Metis Innovative, Genomadix, AIDoc and Arsenal Medical; equity interest in Proprio, Stroke Diagnostics, Apertur, Stereotaxis, Fluid Biomed, Synchron and Hyperion Surgical; editorial board of Journal of NeuroInterventional Surgery; Data safety monitoring board of Arsenal Medical. FC reports conflicts of interest with Medtronic, Balt Extrusion (consultant), ClinSearch (core lab), Penumbra, Stryker (payment for reading) and Artedrone (Board); all not directly related to the present work. CC consultant for Medtronic, Microvention, Cerenovus, Stryker, Anaconda, unrelated to the current study.

LinkOut - more resources